Literature DB >> 4191547

Administration of a peripheral decarboxylase inhibitor with L-dopa to depressed patients.

F K Goodwin, H K Brodie, D L Murphy, W E Bunney.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4191547     DOI: 10.1016/s0140-6736(70)91044-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

1.  Correlation of clinical symptoms, HVA and 5-HIAA in csf and plasma L-DOPA in Parkinsonian patients treated with L-DOPA and L-DOPA + RO 4-4602.

Authors:  G Campanella; S Algeri; C Cerletti; E Dolfini; A Jori; F Rinaldi
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

Review 2.  Parkinson's disease and levodopa. A five-year follow-up and review.

Authors:  C H Markham; L J Treciokas; S G Diamond
Journal:  West J Med       Date:  1974-09

Review 3.  [Biochemistry of depression].

Authors:  N Matussek
Journal:  J Neural Transm       Date:  1972       Impact factor: 3.575

Review 4.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

Review 5.  Antiparkinsonian drugs: pharmacological and therapeutic aspects.

Authors:  D B Calne; J L Reid
Journal:  Drugs       Date:  1972       Impact factor: 9.546

6.  On the relationship between L-DOPA therapy and CSF monoamine metabolites in Parkinson's disease.

Authors:  C Casati; A Agnoli; A Jori; E Dolfini
Journal:  Z Neurol       Date:  1973-04-02

Review 7.  [Modern treatment of parkinsonism].

Authors:  W Birkmayer; E Neumayer
Journal:  Z Neurol       Date:  1972

8.  Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitor.

Authors:  U K Rinne; V Sonninen; T Sirtola
Journal:  Z Neurol       Date:  1972

9.  The balance of biogenic amines as condition for normal behaviour.

Authors:  W Birkmayer; W Danielczyk; E Neumayer; P Riederer
Journal:  J Neural Transm       Date:  1972       Impact factor: 3.575

10.  Treatment of Parkinsonism with laevodopa.

Authors:  S F Murphy
Journal:  Ir J Med Sci       Date:  1971-03       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.